Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Dec 15;14(24):6209-17.
doi: 10.1002/j.1460-2075.1995.tb00311.x.

Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma

Affiliations

Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma

B H Ye et al. EMBO J. .

Abstract

The BCL6 gene codes for a zinc-finger transcription factor and is involved in chromosomal rearrangements in 30-40% of diffuse large-cell lymphoma (DLCL). These rearrangements cluster within the 5' regulatory region of BCL6 spanning its first non-coding exon. To determine the functional consequences of these alterations, we have analyzed the structure of the rearranged BCL6 alleles and their corresponding RNA and protein species in two DLCL biopsies and one tumor cell line which carried the t(3;14)(q27;q32) translocation involving the BCL6 and immunoglobulin heavy-chain (IgH) loci. In all three cases, the breakpoints were mapped within the IgH switch region and the BCL6 first intron, leading to the juxtaposition of part of the IgH locus upstream and in the same transcriptional orientation to the BCL6 coding exons. An analysis of cDNA clones showed that these recombinations generate chimeric IgH-BCL6 transcripts which initiated from IgH germline transcript promoters (I mu or I gamma 3), but retain a normal BCL6 coding domain. In the tumor cell line, the chimeric I gamma 3-BCL6 allele, but not the germline BCL6 gene, was transcriptionally active and produced a normal BCL6 protein. These findings indicate that t(3;14) translocations alter BCL6 expression by promoter substitution and imply that the consequence of these alterations is the deregulated expression of a normal BCL6 protein.

PubMed Disclaimer

References

    1. Blood. 1992 Mar 1;79(5):1327-33 - PubMed
    1. Genetics. 1991 Oct;129(2):385-97 - PubMed
    1. Blood. 1992 Aug 15;80(4):879-86 - PubMed
    1. EMBO J. 1993 Mar;12(3):1161-7 - PubMed
    1. Cancer Res. 1993 Jun 15;53(12):2732-5 - PubMed

Publication types

MeSH terms